These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23433891)

  • 41. Urinary bladder carcinoma with a neoplastic squamous component: a mapping study of 31 cases.
    Sakamoto N; Tsuneyoshi M; Enjoji M
    Histopathology; 1992 Aug; 21(2):135-41. PubMed ID: 1505930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo optical coherence tomography feasibility for bladder disease.
    Zagaynova EV; Streltsova OS; Gladkova ND; Snopova LB; Gelikonov GV; Feldchtein FI; Morozov A
    J Urol; 2002 Mar; 167(3):1492-6. PubMed ID: 11832776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update on Dx and management of bladder cancer.
    Trump DL
    Geriatrics; 1982 Jul; 37(7):87-91. PubMed ID: 7200929
    [No Abstract]   [Full Text] [Related]  

  • 45. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions.
    Celis JE; Celis P; Ostergaard M; Basse B; Lauridsen JB; Ratz G; Rasmussen HH; Orntoft TF; Hein B; Wolf H; Celis A
    Cancer Res; 1999 Jun; 59(12):3003-9. PubMed ID: 10383167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histological classification of urinary bladder cancers in rats induced by N-butyl-n-(4-hydroxybutyl)nitrosamine.
    Fukushima S; Hirose M; Tsuda H; Shirai T; Hirao K
    Gan; 1976 Feb; 67(1):81-90. PubMed ID: 1269859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sarcomatoid carcinoma arising from the diverticulum of the urinary bladder dome: a difficult diagnosis with imaging.
    Kim MY; Jeon YS; Suh CH; Park WH
    AJR Am J Roentgenol; 1999 May; 172(5):1454-5. PubMed ID: 10227546
    [No Abstract]   [Full Text] [Related]  

  • 48. Pitfalls of clinical versus microscpic staging of cancer of the bladder in relationship to potential curability.
    Baker R
    Am Surg; 1970 May; 36(5):269-75. PubMed ID: 5439001
    [No Abstract]   [Full Text] [Related]  

  • 49. Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance.
    Zhong M; Gersbach E; Rohan SM; Yang XJ
    Arch Pathol Lab Med; 2013 Mar; 137(3):371-81. PubMed ID: 23451748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Critical study of several histoprognostic factors concerning epidermoid type transitional cell carcinomas and vesical epidermoid carcinomas. Appropos of 107 cases].
    Lefèvre M; Crouzet T; Bouissou H
    Arch Anat Cytol Pathol; 1977; 25(4):277-82. PubMed ID: 603263
    [No Abstract]   [Full Text] [Related]  

  • 51. Bladder-sparing surgery and continent urinary diversion using the appendix (Mitrofanoff procedure) for urethral cancer.
    Kobayashi M; Nomura M; Yamada Y; Fujimoto N; Matsumoto T
    Int J Urol; 2005 Jun; 12(6):581-4. PubMed ID: 15985083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry.
    Lopez-Beltran A; Requena MJ; Alvarez-Kindelan J; Quintero A; Blanca A; Montironi R
    J Clin Pathol; 2007 Mar; 60(3):332-5. PubMed ID: 16882698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current practice of urinary bladder cytology.
    Frable WJ; Paxson L; Barksdale JA; Koontz WW
    Cancer Res; 1977 Aug; 37(8 Pt 2):2800-5. PubMed ID: 872107
    [No Abstract]   [Full Text] [Related]  

  • 54. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.
    Shanks JH; Iczkowski KA
    Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.
    Eissa S; Swellam M; Labib RA; El-Zayat T; El Ahmady O
    J Urol; 2009 Mar; 181(3):1353-60. PubMed ID: 19185322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
    Sugano K; Kakizoe T
    Nat Clin Pract Urol; 2006 Dec; 3(12):642-52. PubMed ID: 17149381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bladder leukoplakia].
    Højgaard AD; Jessen AL
    Ugeskr Laeger; 1991 Aug; 153(35):2408-9. PubMed ID: 1949238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bladder cancer: translating molecular genetic insights into clinical practice.
    Cheng L; Zhang S; MacLennan GT; Williamson SR; Lopez-Beltran A; Montironi R
    Hum Pathol; 2011 Apr; 42(4):455-81. PubMed ID: 21106220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of leukoplakia to urothelial malignancy.
    Benson RC; Swanson SK; Farrow GM
    J Urol; 1984 Mar; 131(3):507-11. PubMed ID: 6699992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.